| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Sci Rep] 2022 Apr 12; Vol. 12 (1), pp. 6136. <i>Date of Electronic Publication: </i>2022 Apr 12.
- MeSH Terms: Antioxidants* / pharmacology ; Antioxidants* / therapeutic use ; Gastroesophageal Reflux* / drug therapy ; Animals ; Anti-Inflammatory Agents / pharmacology ; Anti-Inflammatory Agents / therapeutic use ; Caffeine / therapeutic use ; Swine ; Wound Healing
- References: Vakil, N., Van Zanten, S. V., Kahrilas, P., Dent, J. & Jones, R. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Off. J. Am. Coll. Gastroenterol. 101, 1900–1920 (2006). (PMID: 10.1111/j.1572-0241.2006.00630.x) ; Nirwan, J. S., Hasan, S. S., Babar, Z.-U.-D., Conway, B. R. & Ghori, M. U. Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): Systematic review with meta-analysis. Sci. Rep. 10, 1–14 (2020). (PMID: 10.1038/s41598-020-62795-1) ; Badillo, R. & Francis, D. Diagnosis and treatment of gastroesophageal reflux disease. World J. Gastrointest. Pharmacol. Therap. 5, 105 (2014). (PMID: 10.4292/wjgpt.v5.i3.105) ; Park, C. H. et al. Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: A prospective multicenter study. Sci. Rep. 10, 1–11 (2020). ; Menezes, M. A. & Herbella, F. A. Pathophysiology of gastroesophageal reflux disease. World J. Surg. 41, 1666–1671 (2017). (PMID: 2825845210.1007/s00268-017-3952-4) ; Chen, J. & Brady, P. Gastroesophageal reflux disease: Pathophysiology, diagnosis, and treatment. Gastroenterol. Nurs. 42, 20–28 (2019). (PMID: 3068870310.1097/SGA.0000000000000359) ; Sadatomi, D., Kono, T., Mogami, S. & Fujitsuka, N. Weak acids induce PGE2 production in human oesophageal cells: Novel mechanisms underlying GERD symptoms. Sci. Rep. 10, 1–13 (2020). (PMID: 10.1038/s41598-020-77495-z) ; Orlando, R. C. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract. Res. Clin. Gastroenterol. 24, 873–882 (2010). (PMID: 21126700299598910.1016/j.bpg.2010.08.008) ; Agostinis, C. et al. Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models. Biomed. Pharmacother. 131, 110752 (2020). (PMID: 3315291810.1016/j.biopha.2020.110752) ; Yang, Y.-X., Lewis, J. D., Epstein, S. & Metz, D. C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296, 2947–2953 (2006). (PMID: 1719089510.1001/jama.296.24.2947) ; Ament, P. W., Dicola, D. & James, M. E. Reducing adverse effects of proton pump inhibitors. Am. Fam. Phys. 86, 66–70 (2012). ; Meghnem, D., Oldford, S. A., Haidl, I. D., Barrett, L. & Marshall, J. S. Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects. Sci. Rep. 11, 1–10 (2021). (PMID: 10.1038/s41598-021-88829-w) ; Food & Drug Administration. FDA Requests Removal of All Ranitidine Products (Zantac) from the Market. https://www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market . (Accessed on June 2021). ; Reynolds, T. & Dweck, A. Aloe vera leaf gel: A review update. J. Ethnopharmacol. 68, 3–37 (1999). (PMID: 1062485910.1016/S0378-8741(99)00085-9) ; Maan, A. A. et al. The therapeutic properties and applications of Aloe vera: A review. J. Herbal Med. 12, 1–10 (2018). (PMID: 10.1016/j.hermed.2018.01.002) ; Chithra, P., Sajithlal, G. & Chandrakasan, G. Influence of Aloe vera on collagen characteristics in healing dermal wounds in rats. Mol. Cell. Biochem. 181, 71–76 (1998). (PMID: 956224310.1023/A:1006813510959) ; Chithra, P., Sajithlal, G. & Chandrakasan, G. Influence of Aloe vera on the glycosaminoglycans in the matrix of healing dermal wounds in rats. J. Ethnopharmacol. 59, 179–186 (1998). (PMID: 950790210.1016/S0378-8741(97)00112-8) ; Fox, L. T. et al. In vitro wound healing and cytotoxic activity of the gel and whole-leaf materials from selected aloe species. J. Ethnopharmacol. 200, 1–7 (2017). (PMID: 2822992010.1016/j.jep.2017.02.017) ; Xintian, W. et al. Effectiveness of aloe vera for acute and chronic wounds: A systematic review. Chin. J. Evid. Based Med. 13, 468–473 (2013). ; Femenia, A., Sánchez, E. S., Simal, S. & Rosselló, C. Compositional features of polysaccharides from Aloe vera (Aloe barbadensis Miller) plant tissues. Carbohyd. Polym. 39, 109–117 (1999). (PMID: 10.1016/S0144-8617(98)00163-5) ; Jettanacheawchankit, S., Sasithanasate, S., Sangvanich, P., Banlunara, W. & Thunyakitpisal, P. Acemannan stimulates gingival fibroblast proliferation; expressions of keratinocyte growth factor-1, vascular endothelial growth factor, and type I collagen; and wound healing. J. Pharmacol. Sci. 109, 525–531 (2009). (PMID: 1937263510.1254/jphs.08204FP) ; Keshavarzi, Z. et al. The effects of aqueous extract of Aloe vera leaves on the gastric acid secretion and brain and intestinal water content following acetic acid-induced gastric ulcer in male rats. Avicenna J. Phytomed. 4, 137 (2014). (PMID: 250503114103709) ; Werawatganon, D. et al. Aloe vera attenuated gastric injury on indomethacin-induced gastropathy in rats. World J. Gastroenterol. 20, 18330 (2014). (PMID: 25561799427796910.3748/wjg.v20.i48.18330) ; Kaithwas, G., Singh, P. & Bhatia, D. Evaluation of in vitro and in vivo antioxidant potential of polysaccharides from Aloe vera (Aloe barbadensis Miller) gel. Drug Chem. Toxicol. 37, 135–143 (2014). (PMID: 2452425910.3109/01480545.2013.834350) ; Akpan, U., Nna, V., Ekpenyong, C., Antai, A. & Osim, E. Protective role of crude Aloe vera gel against gastric ulcers in alloxan-induced diabetic rats. Res. J. Pharm. Biol. Chem. Sci. 5, 129–138 (2014). ; Panahi, Y., Khedmat, H., Valizadegan, G., Mohtashami, R. & Sahebkar, A. Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: A pilot randomized positive-controlled trial. J. Tradit. Chin. Med. 35, 632–636 (2015). (PMID: 2674230610.1016/S0254-6272(15)30151-5) ; Senni, K. et al. Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. Arch. Biochem. Biophys. 445, 56–64 (2006). (PMID: 1636423410.1016/j.abb.2005.11.001) ; Kuda, T. et al. Antioxidant and anti-norovirus properties of aqueous acetic acid macromolecular extracts of edible brown macroalgae. LWT 141, 110942 (2021). (PMID: 10.1016/j.lwt.2021.110942) ; Phull, A.-R., Majid, M., Haq, I.-U., Khan, M. R. & Kim, S. J. In vitro and in vivo evaluation of anti-arthritic, antioxidant efficacy of fucoidan from Undaria pinnatifida (Harvey) Suringar. Int. J. Biol. Macromol. 97, 468–480 (2017). (PMID: 2810437110.1016/j.ijbiomac.2017.01.051) ; Mak, W., Hamid, N., Liu, T., Lu, J. & White, W. Fucoidan from New Zealand Undaria pinnatifida: Monthly variations and determination of antioxidant activities. Carbohyd. Polym. 95, 606–614 (2013). (PMID: 10.1016/j.carbpol.2013.02.047) ; Phull, A. R. & Kim, S. J. Fucoidan as bio-functional molecule: Insights into the anti-inflammatory potential and associated molecular mechanisms. J. Funct. Foods 38, 415–426 (2017). (PMID: 10.1016/j.jff.2017.09.051) ; Phull, A. R. & Kim, S. J. Fucoidan from Undaria pinnatifida regulates type II collagen and COX-2 expression via MAPK and PI3K pathways in rabbit articular chondrocytes. Biologia 72, 1362–1369 (2017). (PMID: 10.1515/biolog-2017-0158) ; Andryukov, B. G. et al. Sulfated polysaccharides from marine algae as a basis of modern biotechnologies for creating wound dressings: Current achievements and future prospects. Biomedicines 8, 301 (2020). (PMID: 755479010.3390/biomedicines8090301) ; Andrews, G. P., Laverty, T. P. & Jones, D. S. Mucoadhesive polymeric platforms for controlled drug delivery. Eur. J. Pharm. Biopharm. 71, 505–518 (2009). (PMID: 1898405110.1016/j.ejpb.2008.09.028) ; Accili, D., Menghi, G., Bonacucina, G., Di Martino, P. & Palmieri, G. F. Mucoadhesion dependence of pharmaceutical polymers on mucosa characteristics. Eur. J. Pharm. Sci. 22, 225–234 (2004). (PMID: 1519657810.1016/j.ejps.2003.12.011) ; Di Simone, M. P. et al. Barrier effect of Esoxx(®) on esophageal mucosal damage: Experimental study on ex-vivo swine model. Clin. Exp. Gastroenterol. 5, 103–107 (2012). (PMID: 22767997338783210.2147/CEG.S31404) ; Batchelor, H. K. et al. An in vitro mucosal model for prediction of the bioadhesion of alginate solutions to the oesophagus. Int. J. Pharm. 238, 123–132 (2002). (PMID: 1199681610.1016/S0378-5173(02)00062-5) ; Lange, S., Delbro, D. S. & Jennische, E. Evans blue permeation of intestinal mucosa in the rat. Scand. J. Gastroenterol. 29, 38–46 (1994). (PMID: 812817610.3109/00365529409090435) ; Kitajima, S., Takuma, S. & Morimoto, M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp. Anim. 48, 137–143 (1999). (PMID: 1048001810.1538/expanim.48.137) ; Nosrati, H. et al. Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis. J. Nanobiotechnol. 19, 1 (2021). (PMID: 10.1186/s12951-020-00755-7) ; Blois, M. S. Antioxidant determinations by the use of a stable free radical. Nature 181, 1199–1200 (1958). (PMID: 10.1038/1811199a0) ; Kedare, S. B. & Singh, R. P. Genesis and development of DPPH method of antioxidant assay. J. Food Sci. Technol. 48, 412–422 (2011). (PMID: 23572765355118210.1007/s13197-011-0251-1) ; Parisi, O. I. et al. Antioxidant and spectroscopic studies of crosslinked polymers synthesized by grafting polymerization of ferulic acid. Polym. Adv. Technol. 21, 774–779 (2010). (PMID: 10.1002/pat.1499) ; Puoci, F. et al. Antioxidant activity of a Mediterranean food product: “fig syrup”. Nutrients 3, 317–329 (2011). (PMID: 22254099325774410.3390/nu3030317) ; Prior, R. L., Wu, X. & Schaich, K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J. Agric. Food Chem. 53, 4290–4302 (2005). (PMID: 1588487410.1021/jf0502698) ; Hu, Y., Xu, J. & Hu, Q. Evaluation of antioxidant potential of aloe vera (Aloe barbadensis miller) extracts. J. Agric. Food Chem. 51, 7788–7791 (2003). (PMID: 1466454610.1021/jf034255i) ; Lee, K. Y., Weintraub, S. T. & Yu, B. P. Isolation and identification of a phenolic antioxidant from Aloe barbadensis. Free Radic. Biol. Med. 28, 261–265 (2000). (PMID: 1128129310.1016/S0891-5849(99)00235-X) ; Parisi, O. I. et al. Mesoporous nanocrystalline TiO2 loaded with ferulic acid for sunscreen and photo-protection: Safety and efficacy assessment. RSC Adv. 6, 83767–83775 (2016). (PMID: 10.1039/C6RA07653J) ; Benevides Bahiense, J. et al. Potential anti-inflammatory, antioxidant and antimicrobial activities of Sambucus australis. Pharm. Biol. 55, 991–997 (2017). (PMID: 28166708613068610.1080/13880209.2017.1285324) ; Pecora, T. M. G. et al. Rheological behavior of a new mucoadhesive oral formulation based on sodium chondroitin sulfate, xyloglucan and glycerol. J. Funct. Biomater. 12, 28 (2021). (PMID: 33925057816777610.3390/jfb12020028) ; Casiraghi, A. et al. In vitro method to evaluate the barrier properties of medical devices for cutaneous use. Regul. Toxicol. Pharmacol. 90, 42–50 (2017). (PMID: 2882287810.1016/j.yrtph.2017.08.007) ; Pellegatta, G. et al. Evaluation of human esophageal epithelium permeability in presence of different formulations containing hyaluronic acid and chondroitin sulphate. Med. Devices (Auckland) 13, 57 (2020). (PMID: 10.2147/MDER.S234810) ; Parisi, O. I. et al. Surface modifications of molecularly imprinted polymers for improved template recognition in water media. J. Polym. Res. 17, 355–362 (2010). (PMID: 10.1007/s10965-009-9322-7) ; Salaroli, R. et al. Barrier effect of a new topical agent on damaged esophageal mucosa: Experimental study on an ex vivo swine model. Clin. Exp. Gastroenterol. 13, 569–576 (2020). (PMID: 33223844767149010.2147/CEG.S269568) ; Wound Healing Assay. https://www.cellbiolabs.com/wound-healing-assays . (Accessed on March 2021). ; Parisi, O. I. et al. Safety and efficacy of dextran-rosmarinic acid conjugates as innovative polymeric antioxidants in skin whitening: What is the evidence? Cosmetics 4, 28 (2017). (PMID: 10.3390/cosmetics4030028)
- Substance Nomenclature: 0 (Anti-Inflammatory Agents) ; 0 (Antioxidants) ; 3G6A5W338E (Caffeine)
- Entry Date(s): Date Created: 20220413 Date Completed: 20220414 Latest Revision: 20221113
- Update Code: 20231215
- PubMed Central ID: PMC9005723
|
